We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
PVLA
101
Palvella Therapeutics
PVLA
$2.25B
$2.25B $156.13 0.27%
HRMY icon
102
Harmony Biosciences
HRMY
$2.22B
$2.22B $38.12 0.99%
BHVN icon
103
Biohaven
BHVN
$2.21B
$2.21B $14.64 1.41%
OCUL icon
104
Ocular Therapeutix
OCUL
$2.2B
$2.2B $10.04 0.59%
PGEN icon
105
Precigen
PGEN
$2.18B
$2.18B $6.10 6.01%
NUVB icon
106
Nuvation Bio
NUVB
$2.18B
$2.18B $6.22 1.97%
ADMA icon
107
ADMA Biologics
ADMA
$2.12B
$2.12B $9.47 0.64%
SEPN
108
Septerna Inc
SEPN
$2.08B
$2.08B $44.50 1.42%
AUPH icon
109
Aurinia Pharmaceuticals
AUPH
$2.06B
$2.06B $15.47 1.91%
GHRS icon
110
GH Research
GHRS
$2.02B
$2.02B $29.49 4.61%
MESO
111
Mesoblast
MESO
$2.02B
$2.02B $15.60 5.4%
STOK icon
112
Stoke Therapeutics
STOK
$2.02B
$2.02B $31.27 0.13%
GENB
113
Generate Biomedicines
GENB
$2.01B
$2.01B $15.64 4.06%
AGIO icon
114
Agios Pharmaceuticals
AGIO
$2B
$2B $33.56 0.27%
NBTX
115
Nanobiotix
NBTX
$1.95B
$1.95B $38.31 0.37%
TSHA icon
116
Taysha Gene Therapies
TSHA
$1.94B
$1.94B $5.95 0.67%
ZBIO
117
Zenas BioPharma
ZBIO
$1.92B
$1.92B $29.51 1.06%
DMRA
118
Damora Therapeutics
DMRA
$1.92B
$1.92B $31.04 1.01%
SRPT icon
119
Sarepta Therapeutics
SRPT
$1.91B
$1.91B $18.10 1.74%
KARD
120
Kardigan Inc
KARD
$1.89B
$1.89B $20.20 7.38%
LKFT
121
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.8B
$1.8B $27.53 1.82%
ZYME icon
122
Zymeworks
ZYME
$1.78B
$1.78B $25.12 2.48%
AAPG
123
Ascentage Pharma
AAPG
$1.77B
$1.77B – –
SNDX icon
124
Syndax Pharmaceuticals
SNDX
$1.77B
$1.77B $19.84 3.98%
IMCR icon
125
Immunocore
IMCR
$1.76B
$1.76B $34.21 0.03%
3 4
5
6 7

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 571 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.29T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $128B, Regeneron Pharmaceuticals (REGN) at $82.7B and argenx (ARGX) at $53.3B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 232 funds opened new positions, taking total fund holders up 124 (24%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.